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Results:
 Monte Carlo calculation showed that out-of-field dose was dominated 
by scattered radiation caused by the linac head, and the internal body 
scattering was not significant. This tendency was confirmed for not 
only ovary which is distant from the treated breast but also much 
nearer contralateral breast. Using RAND phantom, measured dose 
using the glass rod dosimeter agreed with Monte Carlo calculation 
within an estimated calculation precision.  
Conclusions: We have shown that out-of-field dose can be evaluated 
by Monte Carlo codes, and the dose contributions from internal body 
scattering and linac head scattering can be separately calculated. Our 
findings were that the out-of-field doses were mainly from linac head 
scattering,suggesting that a combination of a delivery with lower 
monitor units and reduced collimator transmission leads to minimum 
out-of-field dose. In view of this, the authors believe that VMAT 
delivery with a multileaf collimator having minimum leaf transmission 
would minimize out-of-field dose and thus secondary cancer risk.  
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Purpose/Objective: To improve the estimates of organ doses from 
nuclear medicine procedures using iodine 131 (I-131). To this end, we 
calculated a comprehensive set of S values, defined as organ absorbed 
doses per unit of nuclear transition in source regions (mGy/(Bq.s)), for 
I-131 using the latest reference models of the human body, which 
have been developed by the International Commission on Radiological 
Protection (ICRP). We compared our results with the S values from the 
Oak Ridge National Laboratory (ORNL) stylized phantoms, which are 
currently used in clinical dosimetry. 
Materials and Methods: We calculated the I-131 S values for the ICRP 
reference male and female voxel phantoms (ICRP Publication 110), 
using the I-131 photon and electron spectra from ICRP Publication 107 
and a Monte Carlo radiation transport code, MCNPX2.6. For each 
phantom, we automatically defined a uniform distribution of I-131 in 
each of the 53 source regions. We directly computed the S values for 
42 target organs without the calculation of Specific Absorbed Fraction 
(SAF). We obtained the S values from the ORNL stylized phantoms 
from earlier publications for comparison. 
  
Results: We calculated a comprehensive set of S values for I-131 
distributed within 53 source regions of the ICRP female and male 
phantoms and 42 target organs and tissues. We calculated, for the 
first time, S values for some source and target organs (e.g., salivary 
gland) that were not available in the stylized phantoms but are of 
interest in internal dosimetry of I-131. The estimated S values from 
the ICRP female phantom were 1.4 times on average greater than the 
values from the male phantom. The S values for ICRP voxel phantoms 
were 1.4 and 1.9 times greater than the values from ORNL phantoms 
for female and male, respectively. In particular, the ICRP female 
values for stomach contents to the target of breasts, heart wall and 
adrenals were about 2 to 3 times greater than the values for ORNL.  
Conclusions: We updated the existing I-131 S values using the ICRP 
reference adult voxel phantoms featuring more realistic anatomy 
compared with the stylized phantoms. Our set of S values even 
enables to assess mean dose to some organs and tissues for which S 
values were not previously available. Our S values can be applied 
prospectively or retrospectively to calculate radiation doses to anyone 
exposed internally to I-131, including nuclear medicine patients 
treated for thyroid cancer or hyperthyroidism.  
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Purpose/Objective: To compare Acuros XB and Anisotropic Analytic 
Algorithm (AAA) dose calculation algorithms with the Collapsed Cone 
Convolution (CCC) calculations derived from fluence measurements as 
available in COMPASS (IBA Dosimetry) for volumetric modulated arc 
therapy (VMAT). 
Materials and Methods: Five clinical cases were planned with VMAT 
for each of the followings: Brain, Head and Neck, Thorax, Pelvis and 
stereotactical body treatment, SBRT. All fluences acquired with the 
iMatrixx-2D detector on a Clinac-iX (Varian, Palo Alto, USA), 6MV, 
were the input for COMPASS system to calculate the dose distribution 
with CCC inside the patient. Such dose distributions were then 
compared with Acuros XB and AAA calculation from Eclipse treatment 
planning system. Comparison evaluation was based on 3-D gamma 
index with distance-to-agreement and dose difference criteria set to: 
3mm/3% and 2mm/2% for targets, organs at risks (OAR), 50 and 10% 
isodose volumes. DVH of OAR and PTV from plan differences were also 
computed and analysed. 
Results: Study presented good agreement between Acuros XB or AAA 
and CCC.  
From the 3-D gamma analysis, the percentage of points passing the 
gamma criteria of 3mm/3% for target are shown in the table: 
 
 CCCvsAcuros CCCvsAAA AAAvsAcuros 
Brain 99.4±0.5 99.4±0.9 97.6±3.2 
H&N 99.5±0.6 99.3±1.1 98.1±2.1 
Thorax 99.9±0.1 99.3±0.5 97.9±1.1 
Pelvis 99.6±0.4 97.5±4.6 97.9±2.4 
SBRT 100.0±0.0 97.7±5.0 98.2±3.6 
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Similar results were obtained for the different OAR.  
From plan difference the mean doses of OAR and targets were within 
±1%. 
Conclusions: This study showed the good agreement of CCC 
calculations from measured fluences with respect to both Acuros XB 
and AAA algorithms from treatment planning system.  
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Purpose/Objective: Aim of this study is to compare dose calculation 
algorithms Analytical Anisotropic Algorithm (AAA) and AcurosXB(AXB) 
in terms of different dose calculation grid sizes for brain cases using 
Volumetric Modulated Arc Therapy(VMAT) where maximum dose is 
more concern for serial organs. 
Materials and Methods: AcurosXB algorithm recently available in 
varian 3D treatment planning system was compared with AAA 
algorithm. In this study we selected 10 brain cases where optic 
apparatus and brainstem very close to or merged within the Planning 
Target Volume(PTV). All the cases 3mm CT slices were taken and full 
arc or semi arc VMAT plans were created using Varian Eclipse 
treatment planning system(TPS)(V10). Plans were optimized using 
Progressive Resolution Optimization(PRO) III algorithm and dose was 
calculated using AAA and AXB algorithms for different grid sizes 
1.5mm, 2.0mm & 2.5mm. Plans were compared dosimetrically in 
terms of dose and volume. PTV was analyzed in terms of maximum 
dose (1% of PTV volume receiving dose), dose received by 95% volume 
of PTV V95% and conformity index(CI) whereas critical organs 
maximum dose was compared for optic chiasma, optic nerve and 
brainstem. In addition Verification plans were created and measured 
for all plans on multi cube phantom (with iMatrixx 2D array) and dose 
calculations were performed with AAA & AXB for the same gird size 
combinations. Measured dose was kept as reference and all other dose 
calculated plans were compared in terms of gamma analysis. 
Results: The mean percentage of PTV maximum dose difference of 
AAA over AXB(taken as reference) was found to be 1.992±0.20, 
1.342±0.76 & 1.599±0.21, the average PTV V95% dose percentage 
difference was 2.822±0.48, 2.825±0.42 & 2.944±0.42 and mean 
Conformity index percentage difference was 5.784±1.34, 5.639±1.73 & 
5.872±1.51 for 1.5mm, 2.0mm & 2.5mm grid sizes respectively. 
Regarding critical organs the mean percentage difference of maximum 
dose for optic chiasm was 1.398±0.27, 1.326±0.23 & 0.780±0.34, left 
optic nerve 0.924±0.43, 1.022±0.20 & 0.498±1.18, right optic nerve 
0.924±0.43, 1.022±0.20 & 0.498±1.18 and brainstem 1.582±0.23, 
1.402±0.23 & 1.590±0.56 for 1.5mm, 2.0mm & 2.5mm grid sizes 
respectively. 2D planar gamma evaluation for 3mm/3% criteria area 
gamma for AAA & AXB were 98.62±0.89, 98.67±0.65, 98.86±0.47 and 
98.87±0.58, 98.94±0.65, 99.14±1.02 for 1.5mm, 2.0mm & 2.5mm grid 
sizes respectively. 
 
 Percentage dose difference (%) Gamma 
analysis 
3mm/3% 
(%) 
PTV Optic 
chiasma 
Lt 
Optic 
nerve 
Rt 
Optic 
nerve 
Brainstem
Grid  Max  V95% CI95 Max Max Max Max Area Area 
1.5mm 1.992 2.822 5.784 1.398 0.924 0.712 1.582 98.62 98.87 
2.0mm 1.342 2.825 5.639 1.326 1.022 0.514 1.402 98.67 98.94 
2.5mm 1.599 2.944 5.872 0.780 0.498 0.222 1.590 98.86 99.14 
 
Conclusions: The results showed that AAA compared with AXB 
overestimates dose by maximum of 3%. Delivered & measured dose 
analysis shows good agreement between measured and AXB than AAA. 
Little overestimation of AAA as compared to AXB can be attributed to 
better modeling of spot size,penumbra & electron contamination in 
AXB. 2.5mm grid size is considered acceptable for most of the VMAT 
brain plans but at least in the high gradient area 1.5mm grid size is 
required.  
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Purpose/Objective: Small animal image-guided precision radiotherapy 
is rapidly advancing through the use of dedicated micro-irradiation 
(micro-IR) devices. However, precise modeling of these devices in 
model-based dose-calculation algorithms such as Monte Carlo(MC) 
simulations continue to present challenges due to the required high 
mechanical tolerances placed on beam collimation, positioning and 
long calculation times. We believe that source generation may benefit 
from alternative analytical techniques since the majority of 
calculation time in MC algorithms is electron transport and 
bremsstrahlung generation that is potential unnecessary given that 
fast spectrum generating codes now exist. The specific intent of this 
investigation is to introduce and demonstrate the viability of a fast 
analytical source model for use in either investigating improvements 
in collimator design or for use in faster dose calculations.  
Materials and Methods: An image-guided small animal micro-IR 
(P225Cx, PXInc, CT, USA) was modeled in MC (EGSnrc, NRC, Ottawa), 
including the electron beam distribution for several circular and 
square fields with sizes ranging from 1-mm to 25-mm in diameter. An 
analytical source model was developed in Matlab (Mathworks, MA, 
USA) that consists of two distinct steps. The first step is the 
generation of a fluence intensity distribution, and the second step 
consists of generating a phase-space file from the fluence intensity 
distribution. The analytical model uses a pinhole image of the focal 
spot, a pre-calculated x-ray spectrum, and collimator-specific 
entrance and exit aperture geometries. MC phase-space files (PSFMC) 
and analytical model phase-space files (PSFAM) were generated at the 
exit of the collimators for a tube potential of 225kVp. Simulations 
using each phase-space file were performed in a voxelized water 
phantom and in a realistic mouse phantom. Beam profiles and 3D dose 
distributions between the analytical source and full MC source model 
were compared.  
Results: Beam profiles between the analytically generated source 
model and the full MC source model agreed well. There was negligible 
difference between the pre-calculated spectrum and the full MC 
generated spectrum. Relative 3D dose distributions were comparable 
with the analytical model showing smoother isodose contours due to 
the nature of the analytical phase-space. The analytical model source 
generation demonstrated a speed increase of 30x over efficient MC 
source generation for the largest beams and were up to 400 times 
faster for the smallest beams. The analytical source model also 
demonstrated that the shape and output of the beam is highly 
dependent on the size and shape of the electron beam distribution 
and collimator alignment.  
Conclusions: The presented analytical source model is a useful tool 
for rapidly generating a source model.  
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Purpose/Objective: To validate a simplified kV x-ray beam model and 
dose computation method (kVDoseCalc) for CBCT in block, round, and 
anthropomorphic geometries.  
Materials and Methods: We characterized Varian® OBI® beam output 
for four imaging modalities using three different energies and two 
different bow tie filters. (See Table 1) 
 
 
The spatially varying spectrum of the beam was obtained by matching 
the nominal kVp and the measured HVL to a spectrum computed using 
the freeware Spektr.1,2 The transverse beam fluence Φ(x)was 
calculated from Eq. (1) using in-air dose measurements. The term 
U(x,E) represents the spectrum obtained from Spektr, while the mass-
absorption coefficient (µen(E)/ρ)was taken from the NIST database.3 A 
similar fluence was obtained along the radial axis. The two fluences 
were multiplied together to create a two-dimensional array that was 
back-projected to the position of the x-ray tube anode to form the x-
ray source.1 This source was used as input for kVDoseCalc,our in-house 
x-ray dose computation software.4 
